BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Lymphocyte
,
DNA fingerprint
,
Trichostatin A
,
rs4950928
,
GATA1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
arsenic sulfide
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Broad Connectivity Map (CMAP 2.0) compound database
Liver Pharmacology and Xenobiotic Response Repertoire
Expression data from human Jurkat T cells exposed to 31 compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Massive human ingestion of orpiment (arsenic trisulfide).
A pathway of the generation of acid mine drainage and release of arsenic in the bioleaching of orpim…
Thioarsenate formation upon dissolution of orpiment and arsenopyrite.
Structural and vibrational properties of arsenic sulfides: alacranite (As8S9).
Comparative pharmaceutico-analytical study of Rasamanikya prepared by two different Shodhana media o…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ